AXOGEN, INC. (NASDAQ:AXGN) Files An 8-K Submission of Matters to a Vote of Security Holders
Item 5.07Submission of Matters to a Vote of Security Holders
On May 24, 2017, AxoGen, Inc. (the Company) held its 2017 Annual
Meeting of Shareholders (the Annual Meeting) to act upon the
matters provided in the Companys 2017 Proxy Statement dated April
7, 2017 (the Proxy Statement). Of the 33,064,026 shares of the
Companys common stock outstanding and eligible to vote at the
Annual Meeting, 29,157,719 shares were present either in person
or by proxy.
The following describes the matters considered by the Companys
shareholders at the Annual Meeting and the results of the votes
cast at the meeting:
Proposal No. 1:To elect the following seven members to the
Companys board of directors (the Board of Directors) to hold
office for the ensuingyear and until their successors are elected
and qualified:
|
Nominee |
For |
Withheld |
Broker Non-Vote |
|
Gregory G. Freitag |
21,016,973 |
488,608 |
7,652,138 |
|
Mark Gold, MD |
20,727,930 |
777,651 |
7,652,138 |
|
Jamie M. Grooms |
20,870,312 |
635,269 |
7,652,138 |
|
Guido J. Neels |
20,715,721 |
789,860 |
7,652,138 |
|
Robert J. Rudelius |
20,459,720 |
1,045,861 |
7,652,138 |
|
Amy Wendell |
20,857,049 |
648,532 |
7,652,138 |
|
Karen Zaderej |
21,100,073 |
405,508 |
7,652,138 |
Proposal No. 2:To approve an amendment and restatement of the
AxoGen 2010 Stock Incentive Plan (the Plan) to increase the
number of shares of common stock of AxoGen authorized for
issuance under the Plan from 5,500,000 to 7,700,000 and to make
certain administrative changesto the Plan (as amended and
restated, the AR 2010 Plan):
|
For |
Against |
Abstain |
Broker NonVote |
|
18,258,225 |
2,864,010 |
257,713 |
7,652,138 |
Proposal No. 3:To approve the AxoGen, Inc. 2017 Employee Stock
Purchase Plan (the ESPP):
|
For |
Against |
Abstain |
Broker NonVote |
|
21,070,772 |
219,352 |
89,824 |
7,652,138 |
Proposal No. 4:To ratify the selection of Lurie, LLP as the
Companys independent registered public accounting firm for the
year ending December 31, 2017:
|
For |
Against |
Abstain |
|
28,553,188 |
226,437 |
252,461 |
As a result, the shareholders: (i) elected each of the seven
nominees as a director of the Company to hold office for the
ensuing year and until their successors are elected and
qualified; (ii) approved the AR 2010 Plan; (iii) approved the
ESPP; and (iv) ratified the appointment of Lurie, LLP as the
Companys independent registered public accounting firm for the
year ending December 31, 2017.
2
AXOGEN, INC. (NASDAQ:AXGN) Recent Trading Information
AXOGEN, INC. (NASDAQ:AXGN) closed its last trading session down -0.15 at 14.85 with 153,600 shares trading hands.
